EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY 4.0

Efficacy and safety of endoscopic cardia constriction ligation with a single-use endoscope versus a reusable endoscope for refractory gastroesophageal reflux disease: protocol for a multicenter randomized controlled trial

Run-Hua Li, Ying-Ying Yang, Wen Xu, Gui-Li Xia, Qing Cheng, Xiao-Bing Cui, Ying Zhu, Xiao-Hua Bao

Frontiers in Medicine · 24.06.2026 · 13

DOI: 10.3389/fmed.2026.1832310 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Medicine, online erschienen am 24.06.2026. Verfasst von Run-Hua Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Reusable endoscopes require reprocessing and may carry potential concerns regarding cross-contamination, whereas single-use endoscopes may reduce infection-related risks and simplify workflow. However, evidence remains limited on whether single-use endoscopes can provide comparable performance in therapeutic upper gastrointestinal procedures requiring stable visualization, reliable suction, retroflexion, and accessory compatibility. Endoscopic cardia constriction with ligation (ECCL) is a minimally invasive endoscopic treatment for refractory gastroesophageal reflux disease (GERD). This multicenter randomized controlled trial aims to compare the efficacy, safety, and procedural feasibility of ECCL performed with a single-use endoscope versus a reusable endoscope in patients with refractory GERD.

Methods

This is a multicenter, open-label, parallel-group, non-inferiority randomized controlled trial. Ninety-eight adults aged 18–80 years with refractory GERD will be randomized 1:1 to undergo ECCL using either a single-use endoscope or a reusable endoscope. Eligible participants must have typical GERD symptoms for at least 6 months, persistent symptoms despite optimized acid-suppressive therapy, and objective evidence supporting GERD diagnosis. ECCL will be performed according to a standardized protocol. Participants will receive standardized post-procedural acid-suppressive therapy for 2 weeks and will be followed at 3 and 6 months. The primary efficacy endpoint is clinically significant symptom improvement, defined as a decrease in GERD-Q score of ≥4 points from baseline. Change in GERD-Q score will also be analyzed as a continuous supportive outcome. Secondary endpoints include procedural feasibility, safety outcomes, operational stability, device malfunction/defect rates, and acid-suppressive medication use after ECCL, including complete discontinuation of PPI/P-CAB therapy at 3 and 6 months.

Discussion

This trial will provide prospective evidence on whether single-use endoscopes can support ECCL with efficacy, safety, and procedural feasibility comparable to reusable endoscopes. By integrating patient-reported outcomes, standardized procedural assessment, device-related events, and post-procedural medication use, this study may inform future clinical application of single-use endoscopes in therapeutic upper gastrointestinal endoscopy. Clinical trial registration ClinicalTrials.gov , identifier NCT07176221.

Schlagwörter

Stichwörter der Autor:innen

disposable endoscopesendoscopic cardia constriction (ECCL)gastroesophageal reflux disease (GERD)infection controlprocedural feasibility and safetyrandomized controlled trialsingle-use endoscope

Autor:innen und Institutionen

  • Department of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • Shenzhen School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China.
  • Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China.
  • Department of Gastroenterology, No. 964th Hospital, Changchun, China.

Zitieren

APA

Li, R. H., Yang, Y. Y., Xu, W., Xia, G. L., Cheng, Q., Cui, X. B., Zhu, Y., & Bao, X. H. (2026). Efficacy and safety of endoscopic cardia constriction ligation with a single-use endoscope versus a reusable endoscope for refractory gastroesophageal reflux disease: protocol for a multicenter randomized controlled trial. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1832310

Vancouver

Li RH, Yang YY, Xu W, Xia GL, Cheng Q, Cui XB, et al. Efficacy and safety of endoscopic cardia constriction ligation with a single-use endoscope versus a reusable endoscope for refractory gastroesophageal reflux disease: protocol for a multicenter randomized controlled trial. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1832310

BibTeX
@article{Li2026,
  author = {Li, Run-Hua and Yang, Ying-Ying and Xu, Wen and Xia, Gui-Li and Cheng, Qing and Cui, Xiao-Bing and Zhu, Ying and Bao, Xiao-Hua},
  title = {Efficacy and safety of endoscopic cardia constriction ligation with a single-use endoscope versus a reusable endoscope for refractory gastroesophageal reflux disease: protocol for a multicenter randomized controlled trial},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1832310}
}
Kostenlos starten →